Cargando…
Disparities in the prevalence of clinical features between systemic juvenile idiopathic arthritis and adult-onset Still’s disease
OBJECTIVE: To compare clinical features and treatments of patients with systemic JIA (sIJA) and adult-onset Still’s disease (AOSD). METHODS: The clinical charts of consecutive patients with sJIA by International League of Association of Rheumatology criteria or AOSD by Yamaguchi criteria were review...
Autores principales: | Ruscitti, Piero, Natoli, Valentina, Consolaro, Alessandro, Caorsi, Roberta, Rosina, Silvia, Giancane, Gabriella, Naddei, Roberta, Di Cola, Ilenia, Di Muzio, Claudia, Berardicurti, Onorina, Iacono, Daniela, Pantano, Ilenia, Rozza, Gelsomina, Rossi, Silvia, De Stefano, Ludovico, Balduzzi, Silvia, Vitale, Antonio, Caso, Francesco, Costa, Luisa, Prete, Marcella, Navarini, Luca, Iagnocco, Annamaria, Atzeni, Fabiola, Guggino, Giuliana, Perosa, Federico, Cantarini, Luca, Frediani, Bruno, Montecucco, Carlomaurizio, Ciccia, Francesco, Cipriani, Paola, Gattorno, Marco, Giacomelli, Roberto, Ravelli, Angelo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9536787/ https://www.ncbi.nlm.nih.gov/pubmed/35078234 http://dx.doi.org/10.1093/rheumatology/keac027 |
Ejemplares similares
-
Managing Adult-onset Still's disease: The effectiveness of high-dosage of corticosteroids as first-line treatment in inducing the clinical remission. Results from an observational study
por: Ruscitti, Piero, et al.
Publicado: (2019) -
Parenchymal lung disease in adult onset Still’s disease: an emergent marker of disease severity—characterisation and predictive factors from Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort of patients
por: Ruscitti, Piero, et al.
Publicado: (2020) -
Cytokine storm syndrome in severe COVID-19
por: Ruscitti, Piero, et al.
Publicado: (2020) -
Incidence of venous thromboembolism in rheumatoid arthritis, results from a “real-life” cohort and an appraisal of available literature
por: Conforti, Alessandro, et al.
Publicado: (2021) -
Blocking CD248 molecules in perivascular stromal cells of patients with systemic sclerosis strongly inhibits their differentiation toward myofibroblasts and proliferation: a new potential target for antifibrotic therapy
por: Di Benedetto, Paola, et al.
Publicado: (2018)